Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Denosumab

Amgen’s Xgeva delays prostate cancer bone pain

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared… Amgen’s Xgeva delays prostate cancer bone pain   



urinary protein1 - vascular diseases1 - american society of nephrology22 - kidney infection4 - cerebral palsy1 - hypogonadal men1 - sex2 - ufe1 - seminal vesicle stones1 - catheter-associated urinary tract infection1 - trisomy1 - av fistula1 - prostatitis2 - atherosclerosis1 - severe kyphoscoliosis1 - harvard school of public health2 - cinacalcet1 - diabetic kidney failure1 - malaise1 - foley catheters1 - symptomatic kidney stones1 - epo1 - urinary system2 - esrd6 - urine production1 - function of dialysis1 - asco1 - sex cords1 - nephrosis1 - canadian medical association journal2 -